HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Featured / The Price of Innovation: The Role of Drug Pricing in Financing Pharmaceutical Innovation

The Price of Innovation: The Role of Drug Pricing in Financing Pharmaceutical Innovation

The debate on drug prices has reached new heights with the controversy around the role of prices in promoting innovation. Critics claim that prices of innovative drugs are excessive and argue that lowering prices will not harm the flourishing innovation. On the opposite end, the pharmaceutical industry insists that restrictive pricing policies will have a detrimental impact on their ability to generate innovation.

Amid these two divergent positions, two health economists have developed a conceptual framework to bring some light to the role played by drug prices in financing pharmaceutical innovation. The framework describes how drug prices influence the ability of pharmaceutical firms to raise money in capital markets and ultimately finance R&D activities. This topic is rarely discussed in the literature; specifically, the need of pharmaceutical firms to secure the finance to fund R&D activities, generally lasting several years before a product reaches the market and becomes profitable.

The authors also argue that value-based pricing (VBP) is a key component of a well-functioning lifecycle of innovation. That is the case because VBP sends the market a clear signal of priorities, and incentivizes purposeful R&D that aims to produce the kind of innovations that meet this demand. It necessarily requires taking a long view by both sides (payers and pharmaceutical industry). This more collaborative approach is particularly critical because deviations from VBP principles, by either firms or payers, will distort access by firms to capital and lead to an undesirable level of innovation in the long term.

This publication is aimed at those interested to learn more about the lifecycle of innovation from a financial perspective, and the role played by drug prices in this cycle.

Santiago MORENO, PhD

www.ncbi.nlm.nih.gov/pmc/articles/PMC6442120/



You might also be interested in:

  • How Can Excessive Price Increases Be Better Regulated? 08/21/2020
  • Are Healthcare Prices in the U.S. Too High, Too Low, or Both? 08/25/2020
  • Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
  • Invoke a 1980's Law to Lower Cost of Remdesivir for COVID-19,… 08/07/2020
  • Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
  • Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020
  • New Program in Pharmaceutical Value Assessment and… 01/22/2021

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Whitepaper: The Role of Centralized Care Management in Value-based Care
  • 2017 In-Depth Outlook on Oncology Report
  • Value-Based Healthcare: Making it Happen
  • Value-Based Contracting for Biopharmaceuticals Moves Forward
  • ICER Releases White Paper on Gene Therapy

Syndicated Reports

  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
  • Biosimilars: US Payer Perspectives
  • KAM Metrics: Driving Efficiency, Measuring Success
HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute